MEDPLUS2024-01-012024-03-31 MEDPLUS2024-01-012024-03-31 MEDPLUS2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member MEDPLUS2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member MEDPLUS2024-03-31 MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue01Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue02Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue03Member MEDPLUS2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue01Member MEDPLUS2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue02Member MEDPLUS2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue03Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults01Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults02Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults03Member MEDPLUS2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults01Member MEDPLUS2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults02Member MEDPLUS2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults03Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets01Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets02Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets03Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member MEDPLUS2024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member MEDPLUS2024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member MEDPLUS2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities03Member MEDPLUS2024-03-31in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543427 MEDPLUS NOTLISTED Medplus Health Services Limited Equity 2023-04-01 2024-03-31 2024-05-28 2024-03-30 INR Millions Yearly 14:30:00 15:55:00 2024-05-28 2024-05-28 true Cash Flow Indirect Declaration of unmodified opinion Multi segment 2024-01-01 2024-03-31 Audited Consolidated 14904980000.00 104590000.00 15009570000.00 122450000.00 11633100000.00 -216580000.00 1606000000.00 251260000.00 592150000.00 701340000.00 14689720000.00 319850000.00 0.00 319850000.00 86820000.00 -102580000.00 -15760000.00 0.00 335610000.00 0.00 0.00 0.00 0.00 335610000.00 -35840000.00 299770000.00 333960000.00 1650000.00 298120000.00 1650000.00 239070000.00 2 2.81 2.79 0.00 0.00 2.81 2.79 Notes to the Audited consolidated financial results 1. The above audited consolidated financial results of MedPlus Health Services Limited ('The Company') and its subsidiaries (together referred as 'The Group') have been prepared in accordance with Indian Accounting Standards ('Ind AS') prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, from time to time. These audited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on May 28, 2024. These financial results have been audited by the Statutory Auditors of the Company and the auditors have expressed an unqualified opinion on the same. 2. During the year ended March 31, 2022, the Company has completed its Initial Public Offering (IPO) of 17,573,342 equity shares of face value of Rs. 2 each for cash at an issue price of Rs. 796 per equity share aggregating to Rs. 13,982.95 million, consisting of Fresh Issue of 7,544,511 equity shares amounting to Rs. 6,000.00 million and an offer for sale of 10,028,831 equity shares amounting to Rs. 7,982.95 million by the Selling Shareholders. Pursuant to the IPO, the equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) with effect from 23 December 2021. The utilization of IPO proceeds received by the Company (net of IPO related expense) is summarized below: Objects as per Prospectus Planned utilisation as per Prospectus Utilisation up to March 31, 2024 Unutilised amount as on March 31, 2024*i) Investment in Subsidiary - Optival Health Solutions Private Limited towards their working capital requirements 4,671.70 4,671.70 - ii) General Corporate Purposes 1,111.03 448.53 662.50 Total 5,782.73 5,120.23 662.50 * The aforesaid unutilised proceeds of Rs. 662.50 million have been placed as fixed deposits with bank. 3.During the year ended March 31, 2024, with respect to the merger between the Company and MHS Pharmaceuticals Private Limited (MHS), a wholly owned subsidiary, the Company has received approval from equity shareholders and trade creditors at their meetings held on December 15, 2023 pursuant to NCLT order dated November 7, 2023. The Company has filed the final petition for approval under Section 232 Read with Section 230 of the Companies Act, 2013 dated December 26, 2023. Further, the hearing for final approval has been adjourned to June 13, 2024. Consequent adjustments in the financial statements will be made on receipt of requisite approval.4.During the Quarter ended 31 March 2023¬, based on Group’s assessment of the future taxable profitability of its subsidiary, Optival Health Solutions Private Limited, the Group has recognized deferred tax assets on unexpired portion of tax incentive available u/s 80JJAA amounting to Rs.97.39 million. 5.The results for the quarter ended March are the balancing amounts between the figures in respect of the full financial year and the published figures upto the third quarter of the respective financial year.6. The earnings per equity share for the quarters are not annualised.7.Pursuant to an assessment of future profitability of the operations of the Holding Company, the management has recognized deferred tax assets amounting to Rs. 33.59 million during the quarter and year ended 31 March 2024 on unused business losses and unabsorbed depreciation of earlier years Multi segment 2023-04-01 2024-03-31 Audited Consolidated 56248550000.00 400080000.00 56648630000.00 445300000.00 45378530000.00 -1907550000.00 6255190000.00 964330000.00 2242140000.00 2536260000.00 55914200000.00 734430000.00 0.00 734430000.00 271030000.00 -192370000.00 78660000.00 0.00 655770000.00 0.00 0.00 0.00 0.00 655770000.00 -550000.00 655220000.00 654730000.00 1040000.00 654180000.00 1040000.00 239070000.00 2 0.00 5.48 5.45 0.00 0.00 5.48 5.45 Other Expenses 701340000.00 Other Expenses 2536260000.00 -5730000.00 3185710000.00 54690000.00 0.00 414510000.00 44670000.00 56120000.00 0.00 0.00 0.00 0.00 0.00 827210000.00 827210000.00 849940000.00 8939640000.00 14372490000.00 13402340000.00 0.00 175040000.00 912090000.00 504730000.00 0.00 325550000.00 1917410000.00 460000.00 355310000.00 15675520000.00 0.00 0.00 30048010000.00 239070000.00 15540250000.00 15779320000.00 15773590000.00 0.00 0.00 9350000.00 9350000.00 324890000.00 0.00 0.00 8680830000.00 9015070000.00 0.00 2530350000.00 705420000.00 3235770000.00 1712710000.00 306730000.00 4140000.00 5259350000.00 14274420000.00 30048010000.00 1 Other Non- Current Asset a ROU Asset 8773.39 b Other tax assets 129.87 c Other non-current assets 36.38 Total 8939.64 2 Other Non-current liabilities a Lease liabilities 8680.83 Total 8680.83 3 Other current liabilities a Lease liabilities 1414.86 b Contract liabilities 140.13 c Other current liabilities 157.72 Total 1712.71 a. Retail 14667680000.00 b. Diagnostic services 232320000.00 c. Others 4980000.00 a. Retail 55490520000.00 b. Diagnostic services 748850000.00 c. Others 9180000.00 14904980000.00 56248550000.00 14904980000.00 56248550000.00 a. Retail 347660000.00 b. Diagnostic services -59780000.00 c. Others 3260000.00 a. Retail 916250000.00 b. Diagnostic services -318100000.00 c. Others 1160000.00 291140000.00 599310000.00 650000.00 650000.00 -29360000.00 -135770000.00 319850000.00 734430000.00 a. Retail 26171180000.00 b. Diagnostic services 1633340000.00 c. Others 2243490000.00 30048010000.00 a. Retail 13309030000.00 b. Diagnostic services 963630000.00 c. Others 1760000.00 14274420000.00 964330000.00 -1961470000.00 0.00 0.00 -42720000.00 0.00 -166680000.00 -108460000.00 0.00 0.00 0.00 59330000.00 0.00 2242140000.00 0.00 -100170000.00 0.00 9160000.00 0.00 0.00 0.00 209380000.00 141040000.00 0.00 0.00 0.00 0.00 168050000.00 0.00 995170000.00 1729600000.00 0.00 0.00 0.00 292230000.00 0.00 1437370000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15560000.00 843990000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 136040000.00 0.00 -135600000.00 0.00 -827990000.00 0.00 0.00 0.00 0.00 0.00 0.00 72310000.00 0.00 0.00 0.00 0.00 1089020000.00 0.00 964330000.00 0.00 0.00 -1981040000.00 -1371660000.00 0.00 -1371660000.00 2283750000.00 912090000.00 -43950000.00 20000.00 -8110000.00 570000.00